Franklin Street Advisors’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Franklin Street Advisors’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-174,875	Closed	-$565K	–	234
2016 Q1	$565K	Sell	174,875 -37,300	-18%	-$138K	0.11%	131
2015 Q4	$1.02M	Buy	212,175 +12,800	+6%	+$72.6K	0.2%	114
2015 Q3	$1.11M	Buy	199,375 +37,800	+23%	+$279K	0.22%	109
2015 Q2	$1.29M	Buy	161,575 +57,300	+55%	+$492K	0.23%	104
2015 Q1	$1.09M	Buy	104,275 +31,100	+43%	+$425K	0.2%	109
2014 Q4	$880K	Buy	73,175 +24,700	+51%	+$375K	0.17%	113
2014 Q3	$828K	Buy	48,475 +32,025	+195%	+$465K	0.16%	129
2014 Q2	$199K	Buy	+16,450	New	+$156K	0.04%	214

Other funds holding BDSI

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

FPC

Falcon Point Capital San Francisco, California $11.9M AUM 55.76% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Emerald Acquisition Seattle, Washington $51.8B AUM

Franklin Street Advisors's BDSI Position: Q2 2016 in Review

Franklin Street Advisors sold out of BioDelivery Sciences International, Inc. (BDSI) in Q2 2016, closing a stake of 174,875 shares — an estimated $565K sold.

Franklin Street Advisors first reported a position in BDSI in Q2 2014 and held it in 8 quarters. The position peaked at $1.29M in Q2 2015. 88 funds tracked by Wall St. Rank hold BDSI as of Q2 2016.

Franklin Street Advisors reported no remaining BioDelivery Sciences International, Inc. position as of Q2 2016 after selling out during the quarter.
Franklin Street Advisors sold 174,875 BioDelivery Sciences International, Inc. shares in Q2 2016, an estimated $565K.
Franklin Street Advisors first reported a position in BioDelivery Sciences International, Inc. in Q2 2014 and held it in 8 quarters.
Franklin Street Advisors's BioDelivery Sciences International, Inc. position peaked at $1.29M in Q2 2015.
88 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q2 2016.

Based on Franklin Street Advisors's 13F filing for Q2 2016, filed 11 Jul 2016.